BridgeBio Pharma (BBIO)
(Real Time Quote from BATS)
$24.09 USD
-0.94 (-3.76%)
Updated Apr 25, 2024 10:32 AM ET
2-Buy of 5 2
F Value D Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/2/24 |
---|---|
Current Quarter | -0.40 |
EPS Last Quarter | -0.96 |
Last EPS Surprise | -1.05% |
ABR | 1.25 |
Earnings ESP
|
-167.77% |
---|---|
Current Year | -3.09 |
Next Year | -2.76 |
EPS (TTM) | -3.94 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 140.06M | 5.08M | 161.59M | 243.09M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 300.00M | 15.00M | 347.80M | 522.60M |
Low Estimate | 1.50M | 1.50M | 6.85M | 134.48M |
Year ago Sales | 1.83M | 1.64M | 9.30M | 161.59M |
Year over Year Growth Est. | 7,553.66% | 209.45% | 1,636.93% | 50.44% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.40 | -0.83 | -3.09 | -2.76 |
# of Estimates | 6 | 4 | 7 | 6 |
Most Recent Consensus | 0.86 | -0.78 | -1.58 | -3.13 |
High Estimate | 0.86 | -0.77 | -1.58 | -1.84 |
Low Estimate | -1.08 | -0.92 | -4.26 | -3.35 |
Year ago EPS | -0.92 | -0.98 | -3.95 | -3.09 |
Year over Year Growth Est. | 56.52% | 15.31% | 21.77% | 10.75% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 2 | 2 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.40 | -0.83 | -3.09 | -2.76 |
7 Days Ago | -0.40 | -0.83 | -3.09 | -2.76 |
30 Days Ago | -0.40 | -0.83 | -3.09 | -2.76 |
60 Days Ago | -0.84 | -0.89 | -3.80 | -3.01 |
90 Days Ago | -0.98 | -0.94 | -3.83 | -3.03 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.08 | -0.83 | -4.26 | -3.16 |
Zacks Consensus Estimate | -0.40 | -0.83 | -3.09 | -2.76 |
Earnings ESP | -167.77% | 0.00% | -37.99% | -14.70% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.96 | -1.08 | -0.98 | -0.92 | NA |
Estimate | -0.95 | -0.86 | -0.86 | -0.84 | NA |
Difference | -0.01 | -0.22 | -0.12 | -0.08 | -0.11 |
Surprise | -1.05% | -25.58% | -13.95% | -9.52% | -12.53% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more